Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

Triple negative breast cancer (TNBC) is characterized by distinctive biological features that confer an aggressive clinical behavior. In TNBC patients, the absence of well-defined driver pathways such as hormonal receptor expression or hyperactivation of the human epidermal growth factor receptor 2...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Main Authors: Pizzuti, Laura, Krasniqi, Eriseld, Barchiesi, Giacomo, Mazzotta, Marco, Barba, Maddalena, Amodio, Antonella, Massimiani, Gioia, Pelle, Fabio, Kayal, Ramy, Vizza, Enrico, Grassadonia, Antonino, Tomao, Silverio, Venuti, Aldo, Gamucci, Teresa, Marchetti, Paolo, Natoli, Clara, Sanguineti, Giuseppe, Ciliberto, Gennaro, Vici, Patrizia
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2019
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6856581/
https://ncbi.nlm.nih.gov/pubmed/31762800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.35109
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares